1345440-61-0

Basic information

• Product Name: C₂₆H₂₀F₂N₆O₄
• Synonyms: C₂₆H₂₀F₂N₆O₄
• CAS NO: 1345440-61-0
• Molecular Weight: 518.479
• Mol File: 1345440-61-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: C₂₆H₂₀F₂N₆O₄(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₆H₂₀F₂N₆O₄(1345440-61-0)
• EPA Substance Registry System: C₂₆H₂₀F₂N₆O₄(1345440-61-0)

Safety Data

• Hazardous Substances Data: 1345440-61-0(Hazardous Substances Data)

Upstream product

• 1203578-70-4 C₉H₅IN₂O₃ 
• 1345447-21-3 5-iodo-2-((2-nitrovinyl)amino)benzoic acid 
• 1345447-25-7 4-chloro-6-iodo-3-nitroquinoline 
• 1204400-23-6 1-(3,4-difluorobenzyl)-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid 
• 1204400-22-5 C₁₃H₁₀F₂N₂O₃ 
• 4774-35-0 methyl 6-oxo-1,6-dihydropyrimidine-5-carboxylate 
• 1204400-85-0 C₁₅H₁₁F₂N₃O₂ 
• 1345447-27-9 C₁₁H₁₀IN₃O₂ 
• 85118-01-0 alpha-bromo-3,4-difluorotoluene 

Relevant articles and documents

NEW CHEMICAL COMPOUNDS

The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, Qa, Qb, QH, L and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.

HETEROCYCLIC CARBOXYLIC ACID AMIDES AS PDK1 INIHIBITORS

The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, Qa, Qb, QH, L and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.